These notices are from federal and state agencies & other public bodies and/or elected officers of state government.  These are for the viewer’s ease of reference and the fact they are listed here does not indicate an acceptance or rejection by the Board.  Licensees and other interested persons should consult their healthcare provider or legal counsel to determine whether and how any resources and information posted here might be useful in your practice during the period of the COVID19 crisis.

*The Board does not provide legal or specific medical advice.

Louisiana State Board of Medical Examiners

• LSBME Guidance on Hydroxychloroquine (4/9/2020)

• Guidance Regarding Elective Surgery Ban (4/3/2020)

• Therapeutic Interchange:  the LSBME removes any restrictions to allow for pharmacies and Pharmacists to engage in therapeutic substitutions as long as these substitutions ensure the health and stability of patients during this pandemic by providing continuous access to essential medications via therapeutic interchange.

• Emergency Rule: Medical Professions; Restricted Temporary Permits; Emergency Temporary Permit (LAC 46:XLV.402 and 412) published in the April 2020 LA Register

• Use of Appropriate Personal Protective Equipment (PPE) Reminder (5/15/2020)

Louisiana Department of Health and/or Office of Public Health

• Medical and Surgical Procedures (3/18/2020)

• Updated Notice on Medical and Surgical Procedures (3/21/2020)

• Algorithm 2 & 3: Interim Guidance (4/1/2020)

• Emergency Order Extension (4/7/2020)

• Louisiana Health Alert Network (LA HAN)--Updated Testing Priorities for the State Lab for Suspected COVID-19 Patients (4/14/2020)

• Pharmacists- COVID Testing 4.15.20 Final Signed (4/15/2020)

• LDH Coronavirus COVID-19 Provider Information

• Guidance on the Provision of Health Care Services in a Non-Discriminatory Manner During the COVID-19 Event (4/16/2020)

• Healthcare Facility Notice/Order Notice #2020-COVID19-ALL-010 (4/20/2020)

• Updated Information on Medical and Surgical Procedures (4/20/2020)

• Healthcare Facility Notice/Order Notice #2020-COVID19-ALL-010 (4/22/2020)

• Clarification of the Louisiana Health Alert Network Message 20-25: Healthcare Facility Notice/Order #2020-COVID19-ALL-010 (4/24/2020)

• Changes to Strategies and Precautions for the Disposition of Patients with COVID-19 in Healthcare Settings (5/2/2020)

• Testing at the State Laboratory (5/3/2020)

• COVID-19 Reporting Guidelines update (5/4/2020)

• Pediatric Multi-System Inflammatory Syndrome Potentially Associated with COVID-19 (5/9/2020

• Pediatric Multi-System Inflammatory Syndrome Potentially Associated with COVID-19 (5/15/2020)

• Emergency Order Extend Previous Orders til further notice (5/15/2020)

• Testing for Coronavirus (COVID-19) in Nursing Homes, Long-Term Care Facilities, and Other Congregate Settings (5/29/2020)

• Healthcare Facility Notice/Order Notice #2020-COVID19-ALL-020 (6/4/2020)

• Order Extending the Medical/Surgical Procedures Emergency Order #2020-COVID-19-ALL-020 (7/2/2020)

• Discontinuation of Transmission-Based Precautions, Disposition of Patients with COVID-19 in Healthcare Settings, and Updated Return to Work Guidance for Healthcare Workers (Interim Guidance) (7/17/2020)

• Multisystem Inflammatory Syndrome in children (MIS-C) associated with COVID-19 (8/11/2020)

• FDA Broadens Emergency Use Authorization for Veklury (remdesivir) to Include All Hospitalized Patients for Treatment of COVID-19 (8/28/2020)

• Update: Nursing home Reporting of COVID-19/SARS-CoV-2 Test Results (9/17/2020)

• Update: Reporting of All COVID-19/SARS-CoV-2 Results (10/20/2020)

• Update: COVID-19 Viral Testing Guidance (10/28/2020)

• Nursing Home Visitation (11/16/2020)

• Requirements for Initial COVID-19 Vaccine Allocation to Hospitals (11/18/2020)

• Quarantine Options for Exposure to COVID-19 (12/7/2020)

• What Clinicians Need to Know About the Pfizer-BioNTech COVID-19 Vaccine (12/12/2020)

• Requirements for Initial COVID-19 Vaccine Allocation to Community Health Clinics (12/22/2020)

• Monoclonal Antibody (mAb) Treatment (12/23/2020)

• SARS-CoV-2 Variant (1/7/2021)

• SARS-CoV-2 Variant with a CORRECTION to the OPH Laboratory's email address (1/11/2021)

• Important Information on BinaxNOW COVID-19 Antigen Testing Supplies (1/16/2021)

• Memorandum to Vaccine Providers on non-patient discrimination (1/19/2021)

• Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States (1/26/2021)

• Preparing for the Potential Management of Anaphylaxis After COVID-19 Vaccination (2/3/2021)

• Protocol for Administering COVID-19 Vaccines (2/9/2021)

• COVID-19 Vaccination Medical Risk Factor Self-Attestation Form (2/18/2021)

• Fact Sheet for Healthcare Providers Administering Vaccine (3/1/2021)

• Janssen (Johnson & Johnson) COVID-19 vaccines (3/1/2021)

• CDC COCA Call: What Clinicians Need to Know About Johnson & Johnson’s Janssen COVID-19 Vaccine (3/2/2021)

• Protocol for Administration of Certain COVID 19 Vaccines (3/3/2021)

• Expansion of COVID-19 Vaccination Eligibility (3/9/2021)

• COVID-19 Vaccination Medical Risk Factor Self-Attestation Form (3/9/2021)

• Viral Transport Media (VTM) Available from OPH (3/16/2021)

• Updated Quarantine Recommendations for Fully Vaccinated Persons Including the General Public, Healthcare Providers, and Congregate Setting Employees (3/17/2021)

• Expansion of COVID-19 Vaccine Eligibility Criteria in Louisiana (3/24/2021)

• PHLEBOTOMISTS ONLY:  Executve Order on the Protocols for Administering Vaccines:  Janssen,  Moderna,  Pfizer (3/25/2021)

• Availability and provision of COVID-19 vaccine in ambulatory medical clinics (4/6/2021)

• Cerebral Venous Sinus Thrombosis with Thrombocytopenia after Receipt of the Johnson & Johnson (J&J) COVID-19 Vaccine (4/15/2021)

• FDA & CDC Lift Recommended Pause on Johnson & Johnson (Janssen/J&J) Vaccine Use (4/24/2021)

• FDA and CDC Authorize Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents aged 12 -15  /  PfizerCOVID-19-Parent-Guardan-Consent-Screening-Form.pdf (5/13/2021)

• FDA Authorizes Refrigerator Storage of Thawed, Undiluted Pfizer Vaccine for Up to 1 Month (5/20/2021)

• EO for Medical and Surgical Procedures Dental Visits Procedures and Surgeries Other Healthcare Services (5/21/2021)

• Flood Relief Emergency Vaccines  -  Flyer  (5/24/2021)

• Clinical Considerations of Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults (5/28/2021)

• Recommendations on Continuing to Vaccinate Adolescents Against COVID-19 (6/25/2021)

• New Recommendations for Masking and Testing Due to an Alarming Increase in COVID-19 Cases (7/23/2021)

• Anti-SARS CoV-2 Antibody Products (7/27/2021)

• Temporary Statewide Mask Mandate Guidance for All Business Types (8/2/2021)

• Viral Transport Media (VTM) and Swabs Available from OPH (8/6/2021)

• Recommendation Against the Use of Corticosteroids to Treat Outpatients with COVID-19 and Recommendations for Vaccination of Persons with Known or Previous COVID-19 Infection (8/9/2021)

• CORRECTED: Additional Doses of COVID-19 Vaccines for Moderately to Severely Immunocompromised People -- Attachment - 3rd Party Attestation Form (8/14/2021)

• FDA Approval of the Pfizer COVID Vaccine (8/24/2021)

• Louisiana Health Alert Network (LA HAN)--Generator Safety Information (9/8/2021)

• Louisiana Health Alert Network (LA HAN)--Reminder of Existing Guidance for Isolation, Quarantine, and Post-exposure Testing for K-12 Students (9/13/2021)

• Clarification of Individuals Eligible for a Booster (Third Dose) of COVID Vaccine in Louisiana  &  Self-Attestation Form (9/21/2021)

• Louisiana's Pfizer-BioNTech COVID-19 Booster Recommendations (9/24/2021)

• LDH views on off-label prescribing (9/24/2021)

• COVID-19 Vaccination for Pregnant People to Prevent Serious Illness, Deaths, and Adverse Pregnancy Outcomes from COVID-19 (9/30/2021)

• CDC’s Recommendation for Booster Shots for Some People Who are Fully Vaccinated With the Pfizer, Moderna, or Johnson and Johnson Vaccines (10/22/2021)

• CDC's Approval of the Pfizer COVID-19 Vaccine for Children 5-11 Years - Pfizer Vaccine Comparison Chart (11/3/2021)

• All Individuals 18 and Over being Eligible for COVID-19 Booster Vaccinations (11/17/2021)

• COVID-19 Omicron Variant (11/29/2021)

• COVID-19 Vaccine Booster Dose/Additional Dose Guidance (1/6/2022)

• Moderna Booster Dose Interval Shortened to 5 months (1/8/2022)

• Therapeutics for Outpatient Use in the Prevention or Treatment of COVID (1/14/2022) and Using Therapeutics to Prevent and Treat COVID-19 (1/14/2022)

• First Cases of Candid auris Identified in Louisiana (1/18/2022)

• Expiration Dates of SELECT Lots of the Point-of-Care Abbott BinaxNow COVID-19 Antigen Tests EXTENDED to 15 months (1/20/2022)

• Clarification of Recommendations for COVID-19 Vaccines for Moderately or Severely Immunocompromised People (1/22/2022)

• Federal Drug Administration (FDA) Limiting the Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant (1/25/2022)

• COVID-19 Vaccination Guidance Updates (2/15/2022)

• FDA Authorizing New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron Variant (2/17/2022)

• Updated Interim Clinical Considerations for COVID-19 Vaccination Guidance (2/24/2022)

• Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 Who are at Increased Risk for Severe Outcomes of COVID-19 (4/25/2022)

• FDA updates guidance regarding the Janssen (Johnson & Johnson) COVID-19 Vaccine (5/7/2022)

• COVID-19 Rebound after Paxlovid Treatment (5/24/2022)

• CDC and FDA expanding eligibility for Moderna and Pfizer-BioNTech COVID-19 Vaccines for ages 6 months and above. 6/20/2022
  COVID-19 Vaccination Schedule
  Moderna COVID-19 Vaccine Presentations
  Pfizer BioNTech COVID-19 Vaccine Presentations

• FDA Authorizes and CDC Recommends Updated COVID-19 Vaccine Boosters Targeted to be More Effective Against Current Variants (9/2/2022)

• FDA Authorizes and CDC Recommends Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups (10/14/2022)

• Updated (Bivalent) COVID-19 Vaccines Authorized for Children Down to 6 Months of Age (12/12/2022)

• Important Updates on COVID-19 Therapeutics for Treatment and Prevention (12/21/2022)

• Preliminary safety signal found in persons aged 65 years and older receiving the updated Pfizer bivalent COVID-19 booster vaccine (1/17/2023)

• Simplified Uses for COVID-19 Vaccines - Dose Charts (4/21/2023)

Louisiana Emergency Response Network

• Decline in Stroke and Heart Attack Activations Across Louisiana Creates Concern (4/21/2020)

City of New Orleans

• NOLA Guidelines for Phase One Re-Opening (5/15/2020)

• Mayoral Proclamation to Further Promulgate Emergency Orders During the State of Emergency Due to COVID-19 (5/15/2020)

Governor's Office (Proclamations)

• 25-JBE-2020-COVID-19

• 27-JBE-2020-COVID-19

• 28 JBE 2020 re Elections-Recheduled

• 29-JBE-2020-Public-Health-Emergency-COVID-19 (003)

• 30 JBE 2020  Additional Proclamation re COVID

• 32-JBE-2020-Public-Health-Emergency

• 33-JBE-2020

• 37-JBE-2020

• 38 JBE 2020- Signed

• 41-JBE-2020-Stay-At-Home-Extended

• 43-JBE-2020-Provisions-for-Unemployment

• 46-JBE-2020-Elections-Rescheduled

• 58-JBE-2020 Phase 1 of Resilient Louisiana

• 59-JBE-2020 Extension of Emergency Provisions

• 74-JBE-2020 Phase 2 of Resilient Louisiana (6/4/2020)

• 75-JBE-2020 Extension of Emergency Provisions (6/4/2020)

• 83-JBE-2020-State-of-Emergency-COVID-19-Resilient-Louisiana-Phase-2 (7/15/2020)

• 84-JBE-2020-State-of-Emergency-COVID-19-Extension-to-July-24.pdf (7/15/2020)

• 89-JBE-2020 Face Masking Order (7/15/2020)

Attorney General's Office

• Potential Immunity For Drs for Treatment of COVID19 (4/7/2020)

Federal Action Notices

• Opening Up America Again -Centers for Medicare & Medicaid Services (CMS) Recommendations Re-opening Facilities to Provide Non-emergent Non-COVID-19 Healthcare: Phase I (4/19/2020)